Cargando…

Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Akiko, Nabeya, Daijiro, Nagano, Hiroaki, Yagi, Nobuhito, Miyagi, Tadayoshi, Kishaba, Tomoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737602/
https://www.ncbi.nlm.nih.gov/pubmed/33343904
http://dx.doi.org/10.1002/rcr2.700
_version_ 1783622970938228736
author Maeda, Akiko
Nabeya, Daijiro
Nagano, Hiroaki
Yagi, Nobuhito
Miyagi, Tadayoshi
Kishaba, Tomoo
author_facet Maeda, Akiko
Nabeya, Daijiro
Nagano, Hiroaki
Yagi, Nobuhito
Miyagi, Tadayoshi
Kishaba, Tomoo
author_sort Maeda, Akiko
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the case of a healthy 52‐year‐old man who had respiratory failure owing to SARS‐CoV‐2 infection and was treated using femoro‐femoral veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) and prone position ventilation (PPV). After this treatment, his blood oxygen levels, chest high‐resolution computed tomography findings, and clinical parameters significantly improved. He was decannulated from VV‐ECMO on day 6 and finally extubated on day 11. To our knowledge, this is the first reported case of SARS‐CoV‐2‐associated acute respiratory distress syndrome that was successfully treated with a combination of femoro‐femoral VV‐ECMO and PPV.
format Online
Article
Text
id pubmed-7737602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-77376022020-12-18 Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment Maeda, Akiko Nabeya, Daijiro Nagano, Hiroaki Yagi, Nobuhito Miyagi, Tadayoshi Kishaba, Tomoo Respirol Case Rep Case Reports Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the case of a healthy 52‐year‐old man who had respiratory failure owing to SARS‐CoV‐2 infection and was treated using femoro‐femoral veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) and prone position ventilation (PPV). After this treatment, his blood oxygen levels, chest high‐resolution computed tomography findings, and clinical parameters significantly improved. He was decannulated from VV‐ECMO on day 6 and finally extubated on day 11. To our knowledge, this is the first reported case of SARS‐CoV‐2‐associated acute respiratory distress syndrome that was successfully treated with a combination of femoro‐femoral VV‐ECMO and PPV. John Wiley & Sons, Ltd 2020-12-15 /pmc/articles/PMC7737602/ /pubmed/33343904 http://dx.doi.org/10.1002/rcr2.700 Text en © 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Maeda, Akiko
Nabeya, Daijiro
Nagano, Hiroaki
Yagi, Nobuhito
Miyagi, Tadayoshi
Kishaba, Tomoo
Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title_full Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title_fullStr Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title_full_unstemmed Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title_short Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
title_sort prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for covid‐19 treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737602/
https://www.ncbi.nlm.nih.gov/pubmed/33343904
http://dx.doi.org/10.1002/rcr2.700
work_keys_str_mv AT maedaakiko pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment
AT nabeyadaijiro pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment
AT naganohiroaki pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment
AT yaginobuhito pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment
AT miyagitadayoshi pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment
AT kishabatomoo pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment